192 related articles for article (PubMed ID: 16276001)
1. A beta-lactamase with reduced immunogenicity for the targeted delivery of chemotherapeutics using antibody-directed enzyme prodrug therapy.
Harding FA; Liu AD; Stickler M; Razo OJ; Chin R; Faravashi N; Viola W; Graycar T; Yeung VP; Aehle W; Meijer D; Wong S; Rashid MH; Valdes AM; Schellenberger V
Mol Cancer Ther; 2005 Nov; 4(11):1791-800. PubMed ID: 16276001
[TBL] [Abstract][Full Text] [Related]
2. Construction, expression and functional characterization of the β-lactamase with αv integrin ligands.
Wang H; Shi PJ; Wu MF; Li N; Zhou XL; Fan FY
Protein Pept Lett; 2010 Dec; 17(12):1562-5. PubMed ID: 20858201
[TBL] [Abstract][Full Text] [Related]
3. Design and synthesis of a beta-lactamase activated 5-fluorouracil prodrug.
Phelan RM; Ostermeier M; Townsend CA
Bioorg Med Chem Lett; 2009 Feb; 19(4):1261-3. PubMed ID: 19167216
[TBL] [Abstract][Full Text] [Related]
4. Molecular evolution of a class C beta-lactamase extending its substrate specificity.
Nukaga M; Haruta S; Tanimoto K; Kogure K; Taniguchi K; Tamaki M; Sawai T
J Biol Chem; 1995 Mar; 270(11):5729-35. PubMed ID: 7890700
[TBL] [Abstract][Full Text] [Related]
5. Characterization of a fusion protein of RGD4C and the β-lactamase variant for antibody-directed enzyme prodrug therapy.
Zhou X; Wang H; Shi P; Meng AM
Onco Targets Ther; 2014; 7():535-41. PubMed ID: 24748803
[TBL] [Abstract][Full Text] [Related]
6. Towards a ligand targeted enzyme prodrug therapy: single round panning of a beta-lactamase scaffold library on human cancer cells.
Shukla GS; Murray CJ; Estabrook M; Shen GP; Schellenberger V; Krag DN
Int J Cancer; 2007 May; 120(10):2233-42. PubMed ID: 17285581
[TBL] [Abstract][Full Text] [Related]
7. Construction, expression, and activities of L49-sFv-beta-lactamase, a single-chain antibody fusion protein for anticancer prodrug activation.
Siemers NO; Kerr DE; Yarnold S; Stebbins MR; Vrudhula VM; Hellström I; Hellström KE; Senter PD
Bioconjug Chem; 1997; 8(4):510-9. PubMed ID: 9258449
[TBL] [Abstract][Full Text] [Related]
8. Cephalosporin derivatives of doxorubicin as prodrugs for activation by monoclonal antibody-beta-lactamase conjugates.
Vrudhula VM; Svensson HP; Senter PD
J Med Chem; 1995 Apr; 38(8):1380-5. PubMed ID: 7731023
[TBL] [Abstract][Full Text] [Related]
9. Antitumor activities of a cephalosporin prodrug in combination with monoclonal antibody-beta-lactamase conjugates.
Vrudhula VM; Svensson HP; Kennedy KA; Senter PD; Wallace PM
Bioconjug Chem; 1993; 4(5):334-40. PubMed ID: 8274516
[TBL] [Abstract][Full Text] [Related]
10. A Fusion Protein of RGD4C and β-Lactamase Has a Favorable Targeting Effect in Its Use in Antibody Directed Enzyme Prodrug Therapy.
Wang H; Zhou XL; Long W; Liu JJ; Fan FY
Int J Mol Sci; 2015 Apr; 16(5):9625-34. PubMed ID: 25927583
[TBL] [Abstract][Full Text] [Related]
11. Modifying the specificity and activity of the Enterobacter cloacae P99 beta-lactamase by mutagenesis within an M13 phage vector.
Siemers NO; Yelton DE; Bajorath J; Senter PD
Biochemistry; 1996 Feb; 35(7):2104-11. PubMed ID: 8652552
[TBL] [Abstract][Full Text] [Related]
12. Structure-function studies of Ser-289 in the class C beta-lactamase from Enterobacter cloacae P99.
Trépanier S; Knox JR; Clairoux N; Sanschagrin F; Levesque RC; Huletsky A
Antimicrob Agents Chemother; 1999 Mar; 43(3):543-8. PubMed ID: 10049265
[TBL] [Abstract][Full Text] [Related]
13. Activity of avibactam against Enterobacter cloacae producing an extended-spectrum class C β-lactamase enzyme.
Lahiri SD; Giacobbe RA; Johnstone MR; Alm RA
J Antimicrob Chemother; 2014 Nov; 69(11):2942-6. PubMed ID: 24986496
[TBL] [Abstract][Full Text] [Related]
14. Cephalosporin prodrugs of paclitaxel for immunologically specific activation by L-49-sFv-beta-lactamase fusion protein.
Vrudhula VM; Kerr DE; Siemers NO; Dubowchik GM; Senter PD
Bioorg Med Chem Lett; 2003 Feb; 13(3):539-42. PubMed ID: 12565967
[TBL] [Abstract][Full Text] [Related]
15. Developing bifunctional beta-lactamase molecules with built-in target-recognizing module for prodrug therapy: identification of Enterobacter Cloacae P99 cephalosporinase loops suitable for randomization and phage-display selection.
Shukla GS; Krag DN
J Mol Recognit; 2009; 22(6):425-36. PubMed ID: 19437416
[TBL] [Abstract][Full Text] [Related]
16. Characterization of a CC49-based single-chain fragment-beta-lactamase fusion protein for antibody-directed enzyme prodrug therapy (ADEPT).
Alderson RF; Toki BE; Roberge M; Geng W; Basler J; Chin R; Liu A; Ueda R; Hodges D; Escandon E; Chen T; Kanavarioti T; Babé L; Senter PD; Fox JA; Schellenberger V
Bioconjug Chem; 2006; 17(2):410-8. PubMed ID: 16536473
[TBL] [Abstract][Full Text] [Related]
17. Extension of resistance to cefepime and cefpirome associated to a six amino acid deletion in the H-10 helix of the cephalosporinase of an Enterobacter cloacae clinical isolate.
Barnaud G; Labia R; Raskine L; Sanson-Le Pors MJ; Philippon A; Arlet G
FEMS Microbiol Lett; 2001 Feb; 195(2):185-90. PubMed ID: 11179650
[TBL] [Abstract][Full Text] [Related]
18. A humanized immunoenzyme with enhanced activity for glucuronide prodrug activation in the tumor microenvironment.
Chen KC; Wu SY; Leu YL; Prijovich ZM; Chen BM; Wang HE; Cheng TL; Roffler SR
Bioconjug Chem; 2011 May; 22(5):938-48. PubMed ID: 21443266
[TBL] [Abstract][Full Text] [Related]
19. Kinetics of turnover of cefotaxime by the Enterobacter cloacae P99 and GCl beta-lactamases: two free enzyme forms of the P99 beta-lactamase detected by a combination of pre- and post-steady state kinetics.
Kumar S; Adediran SA; Nukaga M; Pratt RF
Biochemistry; 2004 Mar; 43(9):2664-72. PubMed ID: 14992604
[TBL] [Abstract][Full Text] [Related]
20. The D-methyl group in beta-lactamase evolution: evidence from the Y221G and GC1 mutants of the class C beta-lactamase of Enterobacter cloacae P99.
Adediran SA; Zhang Z; Nukaga M; Palzkill T; Pratt RF
Biochemistry; 2005 May; 44(20):7543-52. PubMed ID: 15895997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
